Effects of amyloid β-protein on hippocampal long-term potentiation

( views:106, downloads:0 )
Author:
ZHANG Jun-Fang()
YANG Dong()
QI Jin-Shun()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 62, Issue 06, 2010
DOI:
Key Word:

Abstract:

  • [1]Selkoe DJ.Translating cell biology into therapeutic advances in Alzheimer's disease.Nature 1999;399(6738 Suppl):A23-A31.
  • [2]Li YM,Lai MT,Xu M,Huang Q,DiMuzio-Mower J,Sardana MK,Shi XP,Yin KC,Shafer JA,Gardell SJ.Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.Proc Natl Acad Sci U S A 2000;97(11):6138-6143.
  • [3]Qi JS,Qiao yr.Amyloid beta-protein fragment 31-35 forms ion channels in membrane patches excised from rat hippocampal neurons.Neuroscience 2001;105(4):845-852.
  • [4]Clementi ME,Marini S,Coletta M,Orsini F,Giardina B,Misiti F.Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals:Role of the redox state of methionine-35.FEBS Lett 2005;579(13):2913-2918.
  • [5]Richardson JA,Burns DK.Mouse models of Alzheimer's disease:a quest for plaques and tangles.ILAR J 2002;43(2):89-99.
  • [6]Ye L,Qiao JT.Suppressive action produced by beta-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent:it's offset by (-)huperzine A.Neurosci Lett 1999;275(3):187-190.
  • [7]Zhang JM,Wu MN,Qi JS,Qiao yr.Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CAI region of rats in vivo.Synapse 2006,60(4):307-313.
  • [8]Zhang JF,Qi JS,Qiao JT.Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.Neurobiol Learn Mem 2009;91(3):226-234.
  • [9]Jing W,Guo F,Cheng L,Zhang JF,Qi JS.Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.Neurosci Lett 2009;450(3):306-310.
  • [10]Guo F,Jing W,Ma CG,Wu MN,Zhang JF,Li XY,Qi JS.[Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CAI region in vivo.Synapse 2010;64(1):83-91.
  • [11]Wang XH,Li L,Holscher C,Pan YF,Chen XR,Qi JS.Val(8)glucagon-like peptide-1 protects against Abeta 1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.Neuroscience 2010;170(4):1239-1248.
  • [12]Larson J,Lynch G,Games D,Seubert P.Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice.Brain Res 1999;840(1-2):23-35.
  • [13]Postina R,Schroeder A,Dewachter I,Bohl J,Schmitt U,Kojro E,Prinzen C,Endres K,Hiemke C,Blessing M,Flamez P,Dequenne A,Godaux E,van Leuven F,Fahrenholz F.A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.J Clin Invest 2004;113(10):1456-1464.
  • [14]Chapman PF,White (3L,Jones MW,Cooper-Blacketer D,Marshall VJ,lrizarry M,Younkin L,Good MA,Bliss TV,Hyman BT,Younkin SG,Hsiao KK.Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.Nat Neurosci 1999;2(3):271-276.
  • [15]Dominguez-del-Toro E,Rodriguez-Moreno A,Porras-Garcia E,Sanchez-Campusano R,Blanchard V,Laville M,Bohme GA,Benavides J,Deigado-(3arcia JM.An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over-express a mutant form of human APP associated with Alzheimer's disease.Eur J Neurosci 2004;20(7):1945-1952.
  • [16]Klyubin I,Walsh DM,Cullen WK,Fadeeva IV,Anwyl R,Selkoe D J,Rowan MJ.Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.Eur J Neurosci 2004;19(10):2839-2846.
  • [17]Balducci C,Tonini R,Zianni E,Nazzaro C,Fiordaliso F,Salio M,Vismara L,Gardoni F,Di Luca M,Carli M,Forloni (3.Cognitive deficits associated with alteration of synaptic metaplasticity precede plaque deposition in AbetaPP23 transgenic mice.J Alzheimers Dis 2010.[Epub ahead of print]
  • [18]Arendash GW,King DL,Gordon MN,Morgan D,Hatcher JM,Hope CE,Diamond DM.Progressive,age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes.Brain Res 2001;891(1-2):42-53.
  • [19]Battaglia F,Trinchese F,Liu S,Walter S,Nixon RA,Arancio O.Calpain inhibitors,a treatment for Alzheimer's disease:position paper.J Mol Neurosci 2003;20(3):357-362.
  • [20]Trinchese F,Liu S,Battaglia F,Walter S,Mathews PM,Arancio O.Progressive age-related development of Alzheimerlike pathology in APPIPS1 mice.Ann Neurol 2004;55(6):801-814.
  • [21]Gureviciene I,Ikonen S,Gurevicius K,Sarkaki A,van Groen T,Pussinen R,Ylinen A,Tanila H.Normal induction but accelerated decay of LTP in APP + PS 1 transgenic mice.Neurobiol Dis 2004;15(2):188-195.
  • [22]Gong B,Vitolo OV,Trinchese F,Liu S,Shelanski M,Arancio O.Persistent improvement in synaptic and cognitive functions m an Alzheimer mouse model after rolipram treatment.J Clin Invest 2004;114(11):1624-1634.
  • [23]Breyhan H,Wirths O,Duan K,Marcello A,Rettig J,Bayer TA.APP/PS 1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.Acta Nenropathol 2009;117(6):677-685.
  • [24]Gengler S,McClean PL,McCurtin R,Gault VA,Holscher C.VaI(8)GLP-I rescues synaptic plasticity and reduces dense core plaques in APP/PSI mice.Neurobiol Aging 2010.[Epub ahead of print]
  • [25]Lambert MP,Barlow AK,Chromy BA,Edwards C,Freed R,Liosatos M,Morgan TE,Rozovsky I,Trommer B,Viola KL,Wals P,Zhang C,Finch CE,Krafft GA,Klein WL.Diffusible,nonfibrillar ligands derived from Abetal-42 are potent central nervous system neurotoxins.Proc Nail Acad Sci U S A 1998;95(11):6448-6453.
  • [26]Itoh A,Akaike T,Sokabe M,Nitta A,Iida R,Olariu A,Yamada K,Nabeshima T.Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats.Eur J Pharmacol 1999;382(3):167-175.
  • [27]Chen QS,Kagan BL,Hirakura Y,Xie CW.Impairment of hippocampai long-term potentiation by Alzheimer amyloid beta-peptides.J Neurosci Res 2000;60(1):65-72.
  • [28]Cullen WK,Sub YH,Anwyl R,Rowan MJ.Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments.Neuroreport 1997;8(15):3213-3217.
  • [29]Freir DB,Holscher C,Herron CE.Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo.J Neurophysiol 2001;85(2):708-713.
  • [30]Walsh DM,Klyubin I,Fadceva JV,Cullen WK,Anwyl R,Wolfe MS,Rowan MJ,Selkoe DJ.Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal Iong-term potentiation/n vivo.Nature 2002;416(6880):535-539.
  • [31]Wang Q,Walsh DM,Rowan MJ,Selkce DJ,Anwyl R.Block of long-term potentiation by naturally secreted and synthetic amyioid beta-peptide in hippocampal sfices is mediated via activation of the kinases c-Jun N-terminal kinase,cyclindependent kinasc 5,and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.J Neurosci 2004;24(13):3370-3378.
  • [32]Molnar Z,Soos K,Lengyel I,Penke B,Szegodi V,Budai D.Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo.Neuroreport 2004;15(10):1649-1652.
  • [33]Qiu Z,Gruol DL.Intedeukin-6,beta-amyloid peptide and NMDA interactions in rat cortical neurons.J Nenroimmunol 2003;139(1-2):51-57.
  • [34]Szegedi V,Juhasz G,Budai D,Penke B.Divergent effects of Abetal-42 on ionotropic glutamate receptor-mediated responses in CAI neurons in vivo.Brain Res 2005;1062(1-2):120-126.
  • [35]Chen QS,Wei WZ,Shimahara T,Xie CW.Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyros.Neurobiol Learn Mem 2002;77(3):354-371.
  • [36]Zhang JF,Hou L,Gao XP,Guo F,Jing W,Qi JS,Qiao JT.Amyloid β-protein differentially affects NMDA receptorand GABAA receptor-mediated currents in rat hippocampal CAI neurons.Prog Nat Sci 2009;19(8):963-972.
  • [37]Kim JH,Anwyl R,Suh YH,Djamgoz MB,Rowan MJ.Usedependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampns in vivo.J Neurosci 2001;21(4):1327-1333.
  • [38]Niikura Y,Abe K,Misawa M.Involvement of L-type Ca2+ channels in the induction of long-term potentiation in the basolateral amygdala-dentate gyros pathway of anesthetized rats.Brain Res 2004;1017(1-2):218-221.
  • [39]Xie CW.Calcium-regulated signaling pathways:role in amyloid beta-induced synaptic dysfunction.Nenromolecular Med 2004;6(1):53-64.
  • [40]Nomura I,Kato N,Kita T,Takechi H.Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CAI pyramidal neurons.Neurosci Lett 2005;391(1-2):1-6.
  • [41]Raymond CR,Ireland DR,Abraham WC.NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.Brain Res 2003;968(2):263-272.
  • [42]Yamin G.NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.J Neurosci Res 2009;87(8):1729-1736.
  • [43]Knobloch M,Farinelli M,Konietzko U,Nitsch RM,Mansuy IM.Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms.J Neurosci 2007;27(29):7648-7653.
  • [44]Dineley KT,Kayed R,Neugebauer V,Fu Y,Zhang W,Reese LC,Taglialatela G.Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice.J Neurosci Res 2010;88(13):2923-2932.
  • [45]Zeng Y,Zhao D,Xie CW.Neurotrophins enhance CaMKII activity and rescue amyloid-beta-indaced deficits in hippocampal synaptic plasticity.J Alzheimers Dis 2010;21 (3):823-831.
  • [46]Smith JP,Lal V,Bowser D,Cappai R,Masters CL,Ciccotosto GD.Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices.Brain Res 2009;1269:176-184.
  • [47]Chauhan A,Chauhan VP,Brockerhoff H,Wisniewski HM.Action of amyloid beta-protein on protein kinase C activity.Life Sci 1991,49(21):1555-1562.
  • [48]Garrido JL,Godoy JA,Alvarez A,Bronfman M,Inestrosa NC.Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.Faseb J 2002;16(14):1982-1984.
  • [49]Tyszkiewicz JP,Yah Z.beta-Amyloid peptides impair PKCdependent functions of metabotropic glutamate receptors in prefrontal cortical neurons.J Neurophysio12005;93(6):3102-3111.
  • [50]Tong L,Thornton PL,Balazs R,Cotman CW.Beta-amyloid(1-42) impairs activity-dependent cAMP-response elementbinding protein signaling in neurons at concentrations in which cell survival Is not compromised.J Biol Chem 2001;276(20):17301-17306.
  • [51]Vitolo OV,Sant'Angelo A,Costanzo V,Battaglia F,Arancio O,Shelanski M.Amyloid beta-peptide inhibition of the PKA/ CREB pathway and long-term potentiation:reversibility by drugs that enhance cAMP signaling.Proc Nail Acad Sci U S A 2002;99(20):13217-13221.
  • [52]Monfort P,Felipo V.Amyloid-beta impairs and ibuprofen restores the cGMP pathway,synaptic expression of AMPA receptors and long-term potentiation in hippocampus.J Alzbeimers Dis 2010.[Epub ahead of print]
  • [53]Auld DS,Kornecook TJ,Bastianetto S,Quirion R.Alzheimer's disease and the basal forebrain cholinergic system:relations to beta-amyloid peptides,cognition,and treatment strategies.Prog Neurobiol 2002;68(3):209-245.
  • [54]Rowan M J,Klyubin I,Cullen WK,Anwyl R.Synaptic plasticity in animal models of early Alzheimer's disease.Philos Trans R Soc Lond B Biol Sci 2003;358(1432):821-828.
  • [55]Sun MK,Alkon DL.Impairment of hippocampal CAI heterosynaptic transformation and spatial memory by betaamyloid(25-35).J Neurophysiol 2002;87(5):2441-2449.
  • [56]Dineley KT,Westerman M,Bui D,Bell K,Asbe KH,Sweatt JD.Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampel alpha7 nicotinic acetylcholine receptors:In vitro and in vivo mechanisms related to Alzheimer's disease.J Neurosci 2001;21(12):4125-4133.
  • [57]Dziewczapolski G,Glogowski CM,Masliah E,Heinemann SF.Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.J Neurosci 2009;29(27):8805-8815.
  • [58]Chen L,Wang H,Zhang Z,Li Z,He D,Sokabe M.DMXB (GTS-21) ameliorates the cognitive deficits in beta amyloid (25-35(-)) injected mice through preventing the dysfunction of alpha7 nicotinic receptor.J Neurosci Res 2010;88(8):1784-1794.
  • [59]Wu MN,He YX,Guo F,Qi JS.Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CAI region in vivo.Brain Res Bull 2008;77(2-3):84-90.
  • [60]Wallace MN,Geddes JG,Farquhar DA,Masson MR.Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques.Exp Neurol 1997;144(2):266-272.
  • [61]Ali AB.Involvement of post-synaptic kainate receptors during synaptic transmission between unitary connections in rat neocortex.Eur J Neurosci 2003;17(11):2344-2350.
  • [62]Wang Q,Rowan MJ,Anwyl R.Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide.J Neurosci 2004;24(27):6049-6056.
  • [63]Dickey CA,Loring JF,Montgomery J,Gordon MN,Eastman PS,Morgan D.Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein +presenilin-1 transgenic mice.J Neurosci 2003;23(12):5219-5226.
  • [64]Laurén J,Gimbel DA,Nygaard HB,Gilbert JW,Strittmatter SM.Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.Nature 2009;457(7233):1128-1132.
  • [65]Kessels HW,Nguyen LN,Nabavi S,Malinow R.The prion protein as a receptor for amyloid-beta.Nature 2010;466 (7308):E3-E4;discussion E4-E5.
  • [66]Benilova I,De Strooper B.Prion protein in Alzheimer's pathogenesis:a hot and controversial issue.EMBO Mol Med 2010;2(8):289-290.
  • [67]Wu J,Anwyl R,Rowan MJ.beta-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro.Eur J Pharmacol 1995;284(3):RI-R3.
  • [68]Schulz P.Beta-peptides enhance the magnitude and probability of long-term potentiation.Soc Neurosci Abstr 1996;22:2111.
  • [69]McDonald MP,Dahl EE,Overmier JB,Mantyh P,Cleary J.Effects of an exogenous beta-amyioid peptide on retention for spatial learning.Behav Neural Biol 1994;62(1):60-67.
  • [70]Huber G,Bailly Y,Martin JR,Mariani J,Bragg B.Synaptic beta-amyloid precursor proteins increase with learning capacity in rats.Neuroscience 1997;80(2):313-320.
  • [71]Giacchino J,Criado JR,Games D,Henriksen S.In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice.Brain Res 2000;876(1-2):185-190.
  • [72]Schneider I,Reverse D,Dewachter I,Ris L,Caluwaerts N,Kuiperi C,Gilis M,Geerts H,Kretzschmar H,Godaux E,Moechars D,Van Leuven F,Herms J.Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice,decreasing the threshold for excitotoxicity and facilitating long-term potentiation.J B iol Chem 2001;276(15):11539-11544.
  • [73]Parent A,Linden DJ,Sisodia SS,Borchelt DR.Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.Neurobiol Dis 1999;6(1):56-62.
  • [74]Roder S,Danober L,Pozza MF,Lingenhoehl K.Wiederhold KH,Olpe HR.Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice.Neuroscience 2003;120(3):705-720.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn